中文
EN
Home
About Us
About Us
Enterprise Display
Products&Service
APIs&Intermidates
Excipients&Raw Material
News&Events
Company News
Industry News
Join Us
Join Us
Contact Us
Contact Us
Home
>
News&Events
>
Company News
News&Events
Company News
Industry News
More classification
More
Products&Service
Salcaprozate Sodium
Roflumilast
Rivaroxaban
Ezetimibe
Repaglinide
Vandetanib
Prucalopride Succinate
Conivaptan Hydrochloride
Ropinirole Hydrochloride
Dasatinib Monohydrate
Macitentan
Garenoxacin
Crizotinib
Olaparib
Difamilast
Tepotinib Hydrochloride Hydrate
Tanimilast
Foscarbidopa&Foslevodopa
Company News
Tianrui Pharmaceutical's CPHI China 2025 came to a successful conclusion!
Word:
[Big]
[Middle]
[Small]
QR Code
2025/6/26
Viewed:
Share
Go Back
Print
Previous:
The 2025 team-building journey along the Sichuan-Tibet route in southern Anhui for Hefei Tianrui Pharmaceutical Chemistry came to a successful conclusion
Next:
Successful Site Audits Strengthen Company's Standing: Recognition from Local and International Pharmaceutical Leaders
+86(0551)6893 3033
mobile station
[Upward]